Marc Philippon, MD
Managing Partner
The Steadman Clinic
Disclosure(s): Arthrex: Own stock options in a privately held ineligible company (Ongoing), Researcher (Ongoing); bledsoe: Royalties (Ongoing); ConMed: Royalties (Ongoing); DJO: Royalties (Ongoing); hydrocision: Speaker (Terminated, January 1, 2025); MiS: Own stock or stock options in a publicly traded ineligible company (Ongoing); NICE recovery systems: Speaker (Ongoing); Ossur: Researcher (Ongoing); siemens: Researcher (Ongoing); Smith & Nephew: Consultant (Ongoing), Researcher (Ongoing), Royalties (Ongoing)